January 2021

Letter from the Editor

January 1, 2021

Lighting the way… As we say good riddance to 2020, and look toward a more optimistic 2021, we are starting to see some glimmers of light and a more hopeful future. Granted, as they say, hope is not a strategy, but there is hope. At this moment, two COVID-19 vaccines have been approved and millions […]

Upfront

January 1, 2021

DTRA Launches to Democratize and Accelerate Clinical Trials A new global industry coalition — Decentralized Trials & Research Alliance (DTRA) — aims to dramatically increase access for all patient populations in clinical trials and research. DTRA’s goal is to unite stakeholders, including healthcare companies, regulators, patient groups, and research organizations, to make clinical trial participation […]

Trend Tracking

January 1, 2021

The industry is moving fast, and our community of experts weigh in on the top trends they are watching. Welcome to 2021. This is the first in a series of Trend Tracking updates that we will be publishing throughout the year. Given the current state of, well everything, we decided to highlight the trends that […]

Artificial Intelligence

January 1, 2021

AdventHealth, Berg tap AI to Reduce Mortality in COVID-19 Patients Trend Watch: Collaborations Combine AI and RWE to Combat COVID and Other Diseases Berg, a clinical-stage biotech that employs patient biology and AI to research diseases and develop innovative treatments, is collaborating with AdventHealth, a leading nonprofit healthcare system, aimed at improving patient outcomes and […]

Innovator’s Journey

January 1, 2021

Every entrepreneur’s path is unique, yet they share some core characteristics. They are willing to take calculated risks, they are visionary, they are fearless, and they are always thinking about the next big thing. The statistics are somewhat sobering: 20% of new companies fail in their first year, and only 50% survive through their fifth […]

SHOWCASE: Virtual Health: A Virtual Awakening: COVID-19 Brings Healthcare Revolution

January 1, 2021

Healthcare delivery has undergone a dramatic shift in the wake of the COVID-19 pandemic. Virtual health has been around for more than a decade, but adoption has been slow. However, thanks to advances in technology and the global pandemic that have impacted all areas of health, healthcare is being brought into patients’ homes via technology-enabled […]

How to Enhance Provider and Patient Engagement in Tech-Savvy Healthcare

January 1, 2021

Pharmaceutical representatives have always been a welcomed resource and consistent office visitor for healthcare providers (HCPs). Today, in a world operating largely virtually, pharma reps are re-strategizing HCP engagement in the same way providers are rethinking patient outreach. For physicians, telehealth has intercepted in-person appointments, and contact tracing has become a priority, limiting office visits. […]

The Explosion of Virtual Health in the Field of Mental Health

January 1, 2021

This year has been an incredibly difficult and stressful one due to the COVID-19 pandemic, and for those of us in the United States, the pressures have only been exacerbated by ongoing incidents of racial injustice and political turmoil. These circumstances have all placed an enormous amount of pressure on those who already deal with […]

Combating Telehealth Distractions With Innovation

January 1, 2021

It’s unsurprising that 2020 has spurred rapid growth for digital health. COVID-19 forced patients and healthcare professionals alike to rethink healthcare access, delivery, and management, with technology central to this reimagination. There was no brighter star in this new world than telemedicine. eMarketer reports that in 2020, 41.7 million adults in the United States have […]

SHOWCASE: High-Science Brands: Laying the Groundwork for High-Science Brands

January 1, 2021

Cell and gene therapies, immunotherapies, RNA interference (RNAi) – innovative scientific breakthroughs have the potential to change the course of treatment for severe diseases such as cancer and devastating rare diseases. The gene therapy market is predicted to rise to $35.67 billion by 2027 from $3.61 billion in 2019 thanks to technological advances aimed at […]

High-Efficiency Commercialization for High-Science Brands

January 1, 2021

In the expanding arena of high-science brands, or high-stake, complex therapies, time is not a luxury that patients, providers or pharma manufacturers have on their side. Patients with rare and complex diseases, cancer patients in particular, need access to life-saving therapies without delay. Providers with cancer patients must understand how to navigate the system and […]

Print Is Alive and Well

January 1, 2021

The pandemic has increased the use of digital solutions, but print still brings plenty of value to pharma marketing. For the past three holiday shopping seasons, Amazon, the second-most valuable company in the United States, valued at $1.7 trillion, has issued printed toy catalogs. Why would such a successful e-commerce company based on a digital […]

Digital Influencers

January 1, 2021

Influencers have the power to positively change the status quo because of their authority, knowledge, position, or relationship with their audience. The global digital health market is expected to generate revenue of $884.1 billion, progressing at a 21.8% CAGR during the forecast period (2020-2030), according to one market analyst. The market is growing due to […]

Brigham Hyde, Ph.D. — Data Is Transforming The Landscape

January 1, 2021

From the rise of personalized medicine and value-based healthcare to evolving commercial strategies, the effective utilization of data is critical to solving for better patient outcomes. Brigham Hyde, Ph.D., a highly regarded speaker and thought leader on the value of data and analytics across the life sciences, believes it’s more critical than to reimagine traditional […]

Dan Wilmer — Putting Brands At The Center Of A Patient’s World

January 1, 2021

To connect with consumers, you need to fit into their lives on their terms and empower them with information. As a digital strategist and innovator with a history of building large-scale consumer health businesses, Dan Wilmer recognizes the importance of creating strategies, products, and tools that can result in a meaningful and measurable experience for […]

Breaking New Ground: The Prix Galien Awards 2020

January 1, 2021

At the end of October, 2020, The Galien Foundation presented its 2020 Prix Galien Awards to six products in four categories: Best Pharmaceutical Agent; Best Biotechnology Product; Best Medical Technology; and Best Digital Health Product, a new category for 2020. Created in 1970, the Prix Galien is an international award recognizing innovating therapies that represent […]

The Health Tech Industry: Thriving at Last

January 1, 2021

2020 was a tough year all around, but the health tech industry emerges as a winner during the pandemic. PharmaVOICE started tracking innovation in health technology a couple of years ago. As part of this reporting, we have covered some interesting solutions. In 2020 alone, there was a great deal of activity, much of which […]

Commanders & Chiefs: Biopharma Chief Executive Officers

January 1, 2021

CEOs of biopharma organizations face unprecedented challenges as they lead their companies amid a global pandemic, shoring up their organizations during turmoil, and learning valuable lessons along the way. David Lucchino Maintaining an Entrepreneurial Edge Over the past year, we have put significant focus on maintaining and fostering our culture at a time when the […]

Executive Perspective: The Right Man for the Job A Conversation with Andy Plump, M.D., Ph.D.

January 1, 2021

Timing in life is everything, and for Andy Plump, M.D., Ph.D., taking on the role as president of R&D at Takeda in 2015 has proven to be advantageous not only for the 239-year-old company at a time when it needed a fresh approach, but also for patients around the globe. Back in 2014, Andy was […]

FEEDBACK